What is the recommended dose of Otrivin (xylometazoline) pediatric nasal drops in children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosage of Otrivin (Xylometazoline) Pediatric Nasal Drops in Children

For pediatric patients, xylometazoline (Otrivin) nasal drops should be administered at a concentration of 0.025% with a maximum frequency of three times daily. 1

Age-Specific Dosing Recommendations

  • Infants and children under 2 years: Use of 0.025% concentration, maximum three times daily (under medical supervision) 1
  • Children 2-5 years: One spray per nostril daily of 0.05% concentration 2
  • Children 6-11 years: Two sprays per nostril daily 2
  • Children 12 years and older: Two sprays per nostril once or twice daily 2

Administration Guidelines

  • Apply drops with the child's head tilted backward to ensure proper distribution 1
  • Limit use to short duration (3-5 days) to prevent development of rhinitis medicamentosa 2
  • Allow at least 6 hours between doses to prevent tachyphylaxis 3

Safety Considerations

  • Xylometazoline appears to be safe in hospitalized infants when used at appropriate doses 1
  • The most common side effects include:
    • Nasal irritation or dryness 2
    • Epistaxis (nosebleeds) - most common adverse effect with probable link to xylometazoline 1
    • Rebound congestion with prolonged use beyond recommended duration 3

Important Precautions

  • Avoid continuous use beyond 3-5 days as this can lead to:
    • Development of tolerance (tachyphylaxis) 3
    • Rebound nasal congestion 3
    • Rhinitis medicamentosa (chemical rhinitis) 2
  • Use with caution in children with:
    • Cardiovascular disease 2
    • Hyperthyroidism 2
    • History of sensitivity to sympathomimetic amines 2

Clinical Pearls

  • Low-dose xylometazoline (0.025%) appears to have a good safety profile in hospitalized infants under medical supervision 1
  • Studies show that the same dose remains effective throughout a treatment period without developing tolerance when used appropriately 4
  • Rebound congestion typically develops after prolonged use (30 days) but may not be evident after shorter courses (10 days) 3
  • For allergic rhinitis specifically, intranasal corticosteroids are generally more effective for long-term management than decongestants 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.